Cargando…
Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264800/ https://www.ncbi.nlm.nih.gov/pubmed/37324024 http://dx.doi.org/10.3389/fonc.2023.1228879 |
| _version_ | 1785058404032577536 |
|---|---|
| author | Liu, Jiahua Ma, Junnan Zhang, Jiarong Li, Chengming Yu, Bowen Choe, Hyok Chol Ding, Kaiyue Zhang, Liu Zhang, Lin |
| author_facet | Liu, Jiahua Ma, Junnan Zhang, Jiarong Li, Chengming Yu, Bowen Choe, Hyok Chol Ding, Kaiyue Zhang, Liu Zhang, Lin |
| author_sort | Liu, Jiahua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10264800 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102648002023-06-15 Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 Liu, Jiahua Ma, Junnan Zhang, Jiarong Li, Chengming Yu, Bowen Choe, Hyok Chol Ding, Kaiyue Zhang, Liu Zhang, Lin Front Oncol Oncology Frontiers Media S.A. 2023-05-31 /pmc/articles/PMC10264800/ /pubmed/37324024 http://dx.doi.org/10.3389/fonc.2023.1228879 Text en Copyright © 2023 Liu, Ma, Zhang, Li, Yu, Choe, Ding, Zhang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Liu, Jiahua Ma, Junnan Zhang, Jiarong Li, Chengming Yu, Bowen Choe, Hyok Chol Ding, Kaiyue Zhang, Liu Zhang, Lin Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title | Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title_full | Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title_fullStr | Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title_full_unstemmed | Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title_short | Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| title_sort | corrigendum: bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022 |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264800/ https://www.ncbi.nlm.nih.gov/pubmed/37324024 http://dx.doi.org/10.3389/fonc.2023.1228879 |
| work_keys_str_mv | AT liujiahua corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT majunnan corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT zhangjiarong corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT lichengming corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT yubowen corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT choehyokchol corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT dingkaiyue corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT zhangliu corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 AT zhanglin corrigendumbibliometricandvisualizedanalysisofdrugresistanceinovariancancerfrom2013to2022 |